Beckman Coulter Diagnostics has announced worldwide availability of the Access 2 immunoassay system with enhanced features. Built upon a 20-year legacy of reliable and efficient performance, the ...
Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient's relative level of antibodies in response to a previous SARS-CoV-2 infection. The assay is an added tool to assess ...
Beckman Coulter has announced that its Access SARS-CoV-2 IgG assay is now available in markets accepting the CE Mark. The company has already shipped tests to more than 400 hospitals, clinics and ...
(RTTNews) - Beckman Coulter announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The test has confirmed 98.3% positive percent agreement ...
Beckman Coulter, a clinical diagnostics leader, today announced the launch of its Access SARS-CoV-2 Immunoglobulin M (IgM) assay in countries accepting the CE Mark. The new IgM antibody test ...
BREA, Calif., Jan. 28, 2020 /PRNewswire/ -- Beckman Coulter, a global leader in clinical diagnostics, today announced that its Access PCT assay has received FDA 510(k) clearance and is now available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results